Skip to main content

Table 2 Patient Reported Site-Specific Fat Changes and Body Image Scale Scores

From: Body image in women with HIV: a cross-sectional evaluation

Body Site

Fat Change (n)

SIBID-S

BIQLI

Face

Fat Hypertrophy (12)

2.7 (2.3, 2.9)**

-0.8 (-1.3, 0.5)*

 

Fat Atrophy (12)

2.6 (2.0, 3.1)**

-1.0 (-1.3, -0.2)

 

No Change (38)

1.7 (0.6, 2.2)

0 (-0.8, 0.4)

Neck

Fat Hypertrophy (15)

2.3 (2.1, 2.8)*

-1.0 (-1.3, 0)

 

Fat Atrophy (1)

3.1**

1.7

 

No Change (46)

1.9 (0.8, 2.5)

-0.2 (-0.9, 0.4)

Arm

Fat Hypertrophy (6)

2.3 (1.9, 3.0)

-0.7 (-1.2, 0.8)

 

Fat Atrophy (17)

2.5 (2.1, 3.0)**

-0.8 (-1.3, 0.2)*

 

No Change (39)

1.8 (0.5, 2.4)

-0.1 (-0.8, 0.6)

Breast

Fat Hypertrophy (18)

2.7 (2.0, 3.0)**

-1.0 (-1.3, -0.2)**

 

Fat Atrophy (6)

2.4 (1.9, 3.0)

0.9 (-1.0, 2.0)

 

No Change (38)

1.8 (0.5, 2.3)

-0.1 (-0.8, 0.4)

Abdomen

Fat Hypertrophy (39)

2.3 (1.7, 2.8)**

-0.7 (-1.2, 0)**

 

No Change (23)

1.3 (0.5, 2.3)

0.2 (-0.4, 0.8)

Leg

Fat Hypertrophy (8)

2.3 (2.1, 3.2)*

-0.8 (-1.1, -0.5)*

 

Fat Atrophy (24)

2.3 (1.6, 2.8)*

-0.5 (-1.2, 1.0)

 

No Change (30)

1.8 (0.5, 2.4)

-0.05 (-0.9, 0.5)

Buttock

Fat Hypertrophy (8)

2.5 (1.0, 2.9)

-0.8 (-1.3, 1.9)

 

Fat Atrophy (17)

2.3 (1.9, 2.7)

-0.8 (-1.2, 0.2)

 

No Change (37)

1.9 (0.7, 2.4)

-0.1 (-0.8, 0.4)

  1. Note: Body Image Scale scores reported as Median (IQR).
  2. **Denotes significant difference between group medians (p < 0.025) as determined by Wilcoxon rank sum test comparing fat change group to "no change" control.
  3. * p ≤ 0.05.